Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Fecal tryptophan metabolite profiling in newborns in relation to microbiota and antibiotic treatment

AC. Aust, V. Vidova, K. Coufalikova, S. Smetanova, K. Kozeluhova, L. Micenkova, P. Videnska, S. Smatana, E. Budinska, I. Borek, P. Janku, J. Klanova, Z. Spacil, V. Thon

. 2024 ; 108 (1) : 504. [pub] 20241105

Language English Country Germany

Document type Journal Article

Grant support
CZ.02.1.01/0.0/ 0.0/15_003/0000469 Ministerstvo Školství, Mládeže a Tělovýchovy
LM2023069 Ministerstvo Školství, Mládeže a Tělovýchovy
65269705 Ministerstvo Školství, Mládeže a Tělovýchovy
LM2023069 Ministerstvo Školství, Mládeže a Tělovýchovy
CZ.02.1.01/0.0/ 0.0/15_003/0000469 Ministerstvo Školství, Mládeže a Tělovýchovy
65269705 Ministerstvo Zdravotnictví Ceské Republiky
857560 HORIZON EUROPE Research Infrastructures

In the first days of life, the newborns' intestinal microbiota develops simultaneously with the intestinal gut barrier and follows intestinal immunity. The mode of delivery shows significant impact on microbial development and, thus, the initiation of the tryptophan catabolism pathway. Further antibiotics (ATB) treatment of mothers before or during delivery affects the microbial and tryptophan metabolite composition of stool of the caesarean- and vaginal-delivered newborns. The determination of microbiome and levels of tryptophan microbial metabolites in meconium and stool can characterize intestinal colonization of a newborn. From 134 samples from the Central European Longitudinal Studies of Parents and Children: The Next Generation (CELSPAC: TNG) cohort study, 16S rRNA gene sequencing was performed, and microbial tryptophan metabolites were quantified using ultra-high-performance liquid chromatography with triple-quadrupole mass spectrometry. Microbial diversity and concentrations of tryptophan metabolites were significantly higher in stool compared to meconium. Treatment of mothers with ATB before or during delivery affects metabolite composition and microbial diversity in stool of vaginal- and caesarean-delivered newborns. Correlation of microbial and metabolite composition shows significant positive correlations of indol-3-lactic acid, N-acetyl-tryptophan and indol-3-acetic acid with Bifidobacterium, Bacteroides and Peptoclostridium. The positive effect of vaginal delivery on newborns' microbiome development is degraded when mother is treated with ATB before or during delivery. KEY POINTS: • Antibiotic treatment diminishes the positive effects of vaginal delivery. • Antibiotic treatment affects metabolite and microbial composition in newborns. • Bifidobacterium and Peptoclostridium could be the producer of indole-lactic acid.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003516
003      
CZ-PrNML
005      
20250206104404.0
007      
ta
008      
250121s2024 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00253-024-13339-4 $2 doi
035    __
$a (PubMed)39500766
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Aust, Anne-Christine $u RECETOX, Faculty of Science, Masaryk University, Kamenice 753/5, pavilion D29/1S101, 625 00, Brno, Czech Republic
245    10
$a Fecal tryptophan metabolite profiling in newborns in relation to microbiota and antibiotic treatment / $c AC. Aust, V. Vidova, K. Coufalikova, S. Smetanova, K. Kozeluhova, L. Micenkova, P. Videnska, S. Smatana, E. Budinska, I. Borek, P. Janku, J. Klanova, Z. Spacil, V. Thon
520    9_
$a In the first days of life, the newborns' intestinal microbiota develops simultaneously with the intestinal gut barrier and follows intestinal immunity. The mode of delivery shows significant impact on microbial development and, thus, the initiation of the tryptophan catabolism pathway. Further antibiotics (ATB) treatment of mothers before or during delivery affects the microbial and tryptophan metabolite composition of stool of the caesarean- and vaginal-delivered newborns. The determination of microbiome and levels of tryptophan microbial metabolites in meconium and stool can characterize intestinal colonization of a newborn. From 134 samples from the Central European Longitudinal Studies of Parents and Children: The Next Generation (CELSPAC: TNG) cohort study, 16S rRNA gene sequencing was performed, and microbial tryptophan metabolites were quantified using ultra-high-performance liquid chromatography with triple-quadrupole mass spectrometry. Microbial diversity and concentrations of tryptophan metabolites were significantly higher in stool compared to meconium. Treatment of mothers with ATB before or during delivery affects metabolite composition and microbial diversity in stool of vaginal- and caesarean-delivered newborns. Correlation of microbial and metabolite composition shows significant positive correlations of indol-3-lactic acid, N-acetyl-tryptophan and indol-3-acetic acid with Bifidobacterium, Bacteroides and Peptoclostridium. The positive effect of vaginal delivery on newborns' microbiome development is degraded when mother is treated with ATB before or during delivery. KEY POINTS: • Antibiotic treatment diminishes the positive effects of vaginal delivery. • Antibiotic treatment affects metabolite and microbial composition in newborns. • Bifidobacterium and Peptoclostridium could be the producer of indole-lactic acid.
650    _2
$a lidé $7 D006801
650    12
$a feces $x mikrobiologie $x chemie $7 D005243
650    12
$a tryptofan $x metabolismus $7 D014364
650    _2
$a novorozenec $7 D007231
650    12
$a antibakteriální látky $7 D000900
650    12
$a střevní mikroflóra $x účinky léků $7 D000069196
650    12
$a RNA ribozomální 16S $x genetika $7 D012336
650    12
$a mekonium $x mikrobiologie $x chemie $7 D008470
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a indoly $x metabolismus $7 D007211
650    _2
$a kyseliny indoloctové $x metabolismus $7 D007210
650    _2
$a vysokoúčinná kapalinová chromatografie $7 D002851
650    _2
$a longitudinální studie $7 D008137
650    _2
$a Bifidobacterium $x metabolismus $x růst a vývoj $7 D001644
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vidova, Veronika $u RECETOX, Faculty of Science, Masaryk University, Kamenice 753/5, pavilion D29/1S101, 625 00, Brno, Czech Republic
700    1_
$a Coufalikova, Katerina $u RECETOX, Faculty of Science, Masaryk University, Kamenice 753/5, pavilion D29/1S101, 625 00, Brno, Czech Republic
700    1_
$a Smetanova, Sona $u RECETOX, Faculty of Science, Masaryk University, Kamenice 753/5, pavilion D29/1S101, 625 00, Brno, Czech Republic
700    1_
$a Kozeluhova, Kristyna $u RECETOX, Faculty of Science, Masaryk University, Kamenice 753/5, pavilion D29/1S101, 625 00, Brno, Czech Republic
700    1_
$a Micenkova, Lenka $u RECETOX, Faculty of Science, Masaryk University, Kamenice 753/5, pavilion D29/1S101, 625 00, Brno, Czech Republic
700    1_
$a Videnska, Petra $u RECETOX, Faculty of Science, Masaryk University, Kamenice 753/5, pavilion D29/1S101, 625 00, Brno, Czech Republic
700    1_
$a Smatana, Stanislav $u RECETOX, Faculty of Science, Masaryk University, Kamenice 753/5, pavilion D29/1S101, 625 00, Brno, Czech Republic
700    1_
$a Budinska, Eva $u RECETOX, Faculty of Science, Masaryk University, Kamenice 753/5, pavilion D29/1S101, 625 00, Brno, Czech Republic
700    1_
$a Borek, Ivo $u Department of Neonatology, University Hospital Brno, Brno, Czech Republic
700    1_
$a Janku, Petr $u Clinic of Gynecology and Obstetrics, University Hospital Brno, Brno, Czech Republic
700    1_
$a Klanova, Jana $u RECETOX, Faculty of Science, Masaryk University, Kamenice 753/5, pavilion D29/1S101, 625 00, Brno, Czech Republic
700    1_
$a Spacil, Zdenek $u RECETOX, Faculty of Science, Masaryk University, Kamenice 753/5, pavilion D29/1S101, 625 00, Brno, Czech Republic
700    1_
$a Thon, Vojtech $u RECETOX, Faculty of Science, Masaryk University, Kamenice 753/5, pavilion D29/1S101, 625 00, Brno, Czech Republic. vojtech.thon@recetox.muni.cz $1 https://orcid.org/0000000194742133 $7 xx0060109
773    0_
$w MED00000493 $t Applied microbiology and biotechnology $x 1432-0614 $g Roč. 108, č. 1 (2024), s. 504
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39500766 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104359 $b ABA008
999    __
$a ok $b bmc $g 2263337 $s 1239523
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 108 $c 1 $d 504 $e 20241105 $i 1432-0614 $m Applied microbiology and biotechnology $n Appl Microbiol Biotechnol $x MED00000493
GRA    __
$a CZ.02.1.01/0.0/ 0.0/15_003/0000469 $p Ministerstvo Školství, Mládeže a Tělovýchovy
GRA    __
$a LM2023069 $p Ministerstvo Školství, Mládeže a Tělovýchovy
GRA    __
$a 65269705 $p Ministerstvo Školství, Mládeže a Tělovýchovy
GRA    __
$a LM2023069 $p Ministerstvo Školství, Mládeže a Tělovýchovy
GRA    __
$a CZ.02.1.01/0.0/ 0.0/15_003/0000469 $p Ministerstvo Školství, Mládeže a Tělovýchovy
GRA    __
$a 65269705 $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a 857560 $p HORIZON EUROPE Research Infrastructures
LZP    __
$a Pubmed-20250121

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...